USPTO serial 88626831
CLOUD SEQUENCING
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PARK, JENNY K
- Law office
- TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CLOUD SEQUENCING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for scientific or research use; reagent kits for preparation or performance of single molecule assays for scientific or research use; reagent kits comprising components for single molecule assays for scientific or research use; kits comprising primarily of reagents, enzymes and/or nucleotides for genetic research diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic test kits for scientific use comprising reagents, flowcells, microfluidic devices, data analysis software and support documentation, namely, instructional manuals, therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small- molecule analysis, single nucleotide polymorphisms analysis, insertion and deletion mutations, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, detection of genomic rearrangements and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small- molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; chemical reagents for scientific use; nucleic acid polymer particles for use in genetic sequencing | ACTIVE | — |
| 005 | Diagnostic preparations for medical and veterinary medical purposes, namely, for the preparation of samples, the modification and manipulation of samples and for the marking, separation, isolation, purification and reproduction and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely, reagents and solvents for medical use for the preparation of samples, the modification and the manipulation of samples and for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes for the preparation of samples, the modification and manipulation of samples and for marking, separation, isolation, purification, reproduction and analysis of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagents, flowcells, solid matrix materials, microfluidic devices, downloadable or non-downloadable software for nucleic acid sequencing and analysis, monitoring and interpreting data from genome analyzer machines, and displaying, organizing, storing, sharing and interpreting DNA data sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising primarily reagents, flowcells, solid matrix materials, microfluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipment, namely, medical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, insertion and deletion polymorphisms, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations and structural variants, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namely, medical diagnostic reagents for RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis, namely, reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes | ACTIVE | — |
| 009 | Laboratory instruments for scientific research, namely, optical detectors for genetic sequencing and biochemical analysis; scientific equipment and instruments, namely, semiconductor chips with integrated sensors for nucleic acid sequencing, semiconductor chip readers and related downloadable or recorded computer software used for nucleic acid sequencing and analysis; genome analyzer machines and related downloadable or recorded computer operating software; downloadable or recorded computer software for monitoring of genome analyzer machines from handheld or mobile wireless communication devices capable of voice, data and/or image transmission; downloadable or recorded computer software for the interpretation of data from the genome analyzer machines; downloadable or recorded computer software for displaying, organizing, storing, sharing and interpreting of DNA data | ACTIVE | — |
| 042 | Computer services, namely, providing an online community for subscribers to participate by sharing and posting articles, videos, and other content, namely, findings in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics; research services, namely, case studies in the fields of and for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, and genetics; leasing of laboratory equipment, namely, genomic sequencers and molecular diagnostics, scientific apparatus and instruments, namely, genomic sequencers and molecular diagnostics; medical research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; DNA sequencing, screening, and analysis services for research purposes; DNA sequencing, screening, and analysis services for use in agricultural, environmental and forensic applications; DNA sequencing, screening, and analysis services for medical research purposes; nucleic acid sequencing, screening, and analysis services for medical research purposes; genomic sequencing, screening, and analysis services for medical research purposes; genetic analysis and reporting services for medical research purposes; providing temporary use of nondownloadable software for displaying, organizing, storing, sharing and interpreting of DNA data; genomic sequencing, screening, and analysis services for non-medical purposes; nucleic acid sequencing, screening, and analysis services for non-medical diagnostic purposes; genetic analysis and reporting services for non-medical purposes; providing temporary use of nondownloadable software for interpretation of data from genome analyzer machines | ACTIVE | — |
| 044 | Medical testing for diagnostic or treatment purposes; DNA sequencing, screening, and analysis services for medical diagnostic purposes; nucleic acid sequencing, screening, and analysis services for medical diagnostic purposes; genomic sequencing, screening, and analysis services for medical diagnostic purposes; genetic analysis and reporting services for medical diagnostic purposes; medical diagnostic testing, monitoring and reporting services in the field of infectious disease identification and surveillance | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Apton Biosystems, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CLOUD SEQUENCING
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 1, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 1, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 21, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 21, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 21, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 30, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 26, 2019 | NWAP | NEW APPLICATION ENTERED | — |